Bladder Cancer

AI Allows Pre-Screening of FGFR3 Mutational Status Using Routine Histology Slides of Muscle-Invasive Bladder Cancer - Beyond the Abstract February 6, 2025

Transformative or Transitional? Deciphering the Role of NIAGARA in Shaping Future Practice - Beyond the Abstract February 6, 2025

Assessing the Influence of Smoking on Inflammatory Markers in Bacillus Calmette Guérin Response Among Bladder Cancer Patients: A Novel Machine-Learning Approach - Beyond the Abstract February 5, 2025

Novel Delivery Mechanisms for Existing Systemic Agents and Emerging Therapies in Bladder Cancer - Beyond the Abstract February 4, 2025

Reflections on the AMBASSADOR Trial: The Role of Adjuvant Pembrolizumab in Muscle-Invasive Urothelial Carcinoma - Beyond the Abstract February 3, 2025

VI-RADS followed by Photodynamic Transurethral Resection of Non-Muscle-Invasive Bladder Cancer vs White-Light Conventional and Second-resection: the 'CUT-less' Randomised Trial Protocol - Beyond the Abstract February 3, 2025

Distinct Gene Expression Patterns Identify Patients who Relapse after Neoadjuvant Pembrolizumab and Radical Cystectomy in the PURE-01 Study - Beyond the Abstract January 23, 2025

State of the Art: The Microbiome in Bladder Cancer - Beyond the Abstract January 21, 2025

Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review - Beyond the Abstract January 10, 2025

A Luminal Non-Coding RNA-Based Genomic Classifier Confirms Favourable Outcomes in Patients with Clinically Organ-Confined Bladder Cancer Treated with Radical Cystectomy - Beyond the Abstract January 9, 2025

Sensitive Detection of Urothelial Cancer via High-volume Urine DNA Analysis - Beyond the Abstract January 9, 2025

Long-Term Recurrence Risk, Metastatic Potential and Length of Cystoscopic Surveillance of Low-Grade Non-Muscle Invasive Bladder Cancer - Beyond the Abstract January 7, 2025

Tumor Location at Trans-Urethral Resection Is Predictive of Ipsilateral Pelvic Lymph-Nodal Metastases in Patients Undergoing Radical Cystectomy for Bladder Cancer - Beyond the Abstract December 10, 2024

Metastasis Development in Non-Muscle-Invasive Bladder Cancer - Beyond the Abstract December 9, 2024

Muscle-Invasive Bladder Cancer in Non-Curative Patients: A Study on Survival and Palliative Care Needs - Beyond the Abstract November 27, 2024

Perioperative Complications and In-Hospital Mortality in Paraplegic Radical Cystectomy Patients - Beyond the Abstract November 21, 2024

Perioperative Platform for Muscle-Invasive Bladder Cancer Trials: Designs and Endpoints - Beyond the Abstract November 21, 2024

Bladder Sparing Options for Muscle-Invasive Bladder Cancer - Beyond the Abstract November 20, 2024

Modulation of the Tumor Microenvironment in Non-Muscle-Invasive Bladder Cancer by OncoTherad® (MRB-CFI-1) Nanoimmunotherapy: Effects on Tumor-Associated Macrophages, Tumor-Infiltrating Lymphocytes, and Monoamine Oxidases - Beyond the Abstract November 20, 2024

MTAP Protein Status Is Highly Concordant with CDKN2A Fluorescent in Situ Hybridization and Allows Stratification of the Luminal Subtype in Muscle-Invasive Bladder Cancer - Beyond the Abstract November 8, 2024

Page 1 of 25